Clonal evolution and KRAS-MET coamplification during secondary resistance to EGFR-targeted therapy in metastatic colorectal cancer

Andrea Sartore Bianchi, Emanuele Valtorta, Alessio Amatu, Silvio Veronese, Calogero Lauricella, Erica Bonazzina, Giulia Siravegna, Mauro Truini, Alberto Bardelli, Salvatore Siena

Research output: Contribution to journalArticle

Original languageEnglish
JournalESMO Open
Publication statusPublished - 2016

Cite this

Bianchi, A. S., Valtorta, E., Amatu, A., Veronese, S., Lauricella, C., Bonazzina, E., Siravegna, G., Truini, M., Bardelli, A., & Siena, S. (2016). Clonal evolution and KRAS-MET coamplification during secondary resistance to EGFR-targeted therapy in metastatic colorectal cancer. ESMO Open.